Allergies, Asthma Exacerbations and Uncontrolled Asthma Management : Episode 3

Opinion

Video

May 15, 2024

Type 2 Inflammation and Biomarkers in Asthma

Author(s):

Nicole Chase, MD, FAAP, FACAAI, FAAAAI,S. Shahzad Mustafa, MD

The panelists explore the significance of type 2 inflammation in asthma, including its role and associated markers, while also delving into their approach to assessing patients whose asthma is triggered or worsened by allergies, examining markers beyond IgE and noting the frequency of patients presenting with asthma symptoms during allergy season without actually having allergic asthma.

EP: 1.External Factors and Seasonality of Asthma

EP: 2.Endotypes and Phenotypes in Asthma

EP: 3.Type 2 Inflammation and Biomarkers in Asthma

EP: 4.Moderate/Severe/Uncontrolled Asthma Classification

EP: 5.Thinking About Endotypes when Managing Asthma

EP: 6.Use of Oral Corticosteroids in Asthma

EP: 7.High Oral Corticosteroid Dose and Exposure in Asthma

EP: 8.Oral Corticosteroid Overuse and Uncontrolled Asthma

EP: 9.Biomarkers and Eosinophil Levels in Severe or Uncontrolled Asthma

EP: 10.Biologics in Asthma

EP: 11.GINA Guidelines and Biologics for Treatment of Asthma

EP: 12.Use of Biologics for Asthma in Patients with Allergies

EP: 13.Treatment of Asthma in Pediatric Patients

EP: 14.Atopic March in Pediatric Patients

EP: 15.Use of Biologics in Pediatric Patients and Conversations with Parents

EP: 16.Biologic Options in Pediatric Asthma

EP: 17.Advice for Clinicians Managing Asthma

Related Videos

Duloxetine for Patients with COPD Suffering from Comorbid Depression

Enhancing Standards for Ethical Responsibilities within Clinical Research

Jennifer Flemming, MD | Credit: AASLD

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.